Insider Transactions in Q2 2023 at Tela Bio, Inc. (TELA)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2023
|
Vincent J Burgess Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,135
+21.98%
|
-
|
|
Jun 01
2023
|
John Nosenzo Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,135
+33.33%
|
-
|
|
Jun 01
2023
|
Kurt Azarbarzin Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,135
+33.33%
|
-
|
|
Jun 01
2023
|
Douglas G Evans Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,135
+33.33%
|
-
|
|
Jun 01
2023
|
Lisa N Colleran Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,135
+33.33%
|
-
|
|
Jun 01
2023
|
Federica F. O'Brien Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,135
+33.33%
|
-
|
|
Apr 21
2023
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
27,700
-0.97%
|
$249,300
$9.41 P/Share
|
|
Apr 20
2023
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
28,300
-0.98%
|
$254,700
$9.43 P/Share
|
|
Apr 19
2023
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
136,000
-4.49%
|
$1,224,000
$9.3 P/Share
|